| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | -774 | -620 | 109 | -986 |
| Net loss | -6,482 | -5,690 | -4,998 | -5,960 |
| Cumulative preferred dividends and undistributed earnings allocated to participating securities b | - | - | - | 1,380 |
| Cumulative preferred dividends | 1,265 | 1,252 | 1,238 | - |
| Net loss attributable to common stockholders, basic | -7,747 | -6,942 | -6,236 | -7,340 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.35 | -0.32 | -0.29 | -0.37 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.35 | -0.32 | -0.29 | -0.37 |
| Weighted-average class a common stock outstanding, basic (in shares) | 21,851,606 | 21,383,852 | 21,326,609 | 19,616,362 |
| Weighted-average class a common stock outstanding, diluted (in shares) | 21,851,606 | 21,383,852 | 21,326,609 | 19,616,362 |
Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. (COCH)